Discontinuous calcitonin treatment of established osteoporosis—effects of withdrawal of treatment
- 1 July 1990
- journal article
- research article
- Published by Elsevier in The American Journal of Medicine
- Vol. 89 (1) , 1-6
- https://doi.org/10.1016/0002-9343(90)90089-v
Abstract
No abstract availableThis publication has 25 references indexed in Scilit:
- Effect of salcatonin given intranasally on early postmenopausal bone loss.BMJ, 1989
- NASAL CALCITONIN FOR TREATMENT OF ESTABLISHED OSTEOPOROSISClinical Endocrinology, 1989
- 1-YEAR CONTROLLED RANDOMISED TRIAL OF PREVENTION OF EARLY POSTMENOPAUSAL BONE LOSS BY INTRANASAL CALCITONINThe Lancet, 1987
- Effects of salmon calcitonin in postmenopausal osteoporosis: A controlled double-blind clinical studyCalcified Tissue International, 1986
- Early Effects of Parathormone and Calcitonin on the Number of Osteoclasts and on Serum-Calcium in RatsActa Orthopaedica, 1983
- Treatment of severe hypecalcaemia with calcitoninMetabolic Bone Disease and Related Research, 1980
- ACUTE EFFECTS OF CALCITONIN ON OSTEOCLASTS IN MANClinical Endocrinology, 1976
- Treatment of Paget's Disease of Bone with Synthetic Salmon CalcitoninBMJ, 1974
- HUMAN CALCITONIN IN THE TREATMENT OF PAGET'S BONE DISEASEThe Lancet, 1971
- Thyrocalcitonin: Effect on Idiopathic HypercalcemiaScience, 1966